I have not had time to go over this with any great deal of thought, but a related site already has some info on this, and as its more up our alley I thought i'd post it.
Have we finally seen Ricaurte and his U.S. government-funded (and influenced) goons blown out of the water? Lets hope so.
==============================================
Long Term Ecstasy Users Don’t Have Brain Damage
Government backed scientists in Germany published new research this week, which failed to find any significant or lasting harm to the brains of heavy ecstasy users.
While the study of past and present heavy users (who averaged 827 and 793 pills respectively) uncovered tiny differences in SERT densities (relating to potential seratonin damage) between current and non-users, the differences disappeared altogether when former heavy users were compared to non users.
“These results were particularly interesting in that they dramatically contradict an American study done by George Ricuarte (funded by the US government) which used similar brain scan techniques and ecstasy users with a similar level of lifetime use, but which claimed to have found massive (as much as 90%) loss of SERT,” said an editorial in the hugely prestigious Journal of Nuclear Medicine.
“This huge discrepancy is both unexplained and troubling, as Ricuarte's claims were used both to justify outlawing ecstasy in the US and as justification for sentencing increases,” the journal added.
http://jnm.snmjournals.org/cgi/content/full/44/3/375
==============================================
Journal of Nuclear Medicine Vol. 44 No. 3 375-384
© 2003 by Society of Nuclear Medicine
--------------------------------------------------------------------------------
Clinical Investigations
Long-Term Effects of "Ecstasy" Use on Serotonin Transporters of the Brain Investigated by PET
Ralph Buchert, PhD1, Rainer Thomasius, MD2, Bruno Nebeling, PhD1, Kay Petersen, PhD2, Jost Obrocki, MD2, Lars Jenicke, MD1, Florian Wilke1, Lutz Wartberg2, Pavlina Zapletalova, MS2 and Malte Clausen, MD1
1 Department of Nuclear Medicine, University Hospital Hamburg-Eppendorf, Hamburg, Germany
2 Department of Psychiatry and Psychotherapy, University Hospital Hamburg-Eppendorf, Hamburg, Germany
Alterations of the serotonergic system due to ecstasy consumption have been extensively documented in recent literature. However, reversibility of these neurotoxic effects still remains unclear. To address this question, PET was performed using the serotonin transporter (SERT) ligand 11C-(+)-McN5652 in a total of 117 subjects subdivided into 4 groups: actual ecstasy users (n = 30), former ecstasy users (n = 29), drug-naive control subjects (n = 29), and subjects with abuse of psychoactive agents other than ecstasy (n = 29). Methods: About 500 MBq 11C-(+)-McN5652 were injected intravenously. Thirty-five scans were acquired according to a dynamic scan protocol of 90 min using a full-ring whole-body PET system. Transaxial slices were reconstructed using an iterative method. Individual brains were transformed to a template defined earlier. Distribution volume ratios (DVRs) were derived by application of a reference tissue approach for reversible binding. Gray matter of the cerebellum served as reference. SERT-rich brain regions—mesencephalon, putamen, caudate, and thalamus—were selected for the evaluation of SERT availability using volumes of interest predefined in the template. Results: Compared with drug-naive control subjects, the DVR in actual ecstasy users was significantly reduced in the mesencephalon (P = 0.004) and the thalamus (P = 0.044). The DVR in former ecstasy users was very close to the DVR in drug-naive control subjects in all brain regions. The DVR in polydrug users was slightly higher than that in the drug-naive control subjects in all SERT-rich regions (not statistically significant). Conclusion: Our findings further support the hypothesis of ecstasy-induced protracted alterations of the SERT. In addition, they might indicate reversibility of the availability of SERT as measured by PET. However, this does not imply full reversibility of the neurotoxic effects.
Have we finally seen Ricaurte and his U.S. government-funded (and influenced) goons blown out of the water? Lets hope so.
==============================================
Long Term Ecstasy Users Don’t Have Brain Damage
Government backed scientists in Germany published new research this week, which failed to find any significant or lasting harm to the brains of heavy ecstasy users.
While the study of past and present heavy users (who averaged 827 and 793 pills respectively) uncovered tiny differences in SERT densities (relating to potential seratonin damage) between current and non-users, the differences disappeared altogether when former heavy users were compared to non users.
“These results were particularly interesting in that they dramatically contradict an American study done by George Ricuarte (funded by the US government) which used similar brain scan techniques and ecstasy users with a similar level of lifetime use, but which claimed to have found massive (as much as 90%) loss of SERT,” said an editorial in the hugely prestigious Journal of Nuclear Medicine.
“This huge discrepancy is both unexplained and troubling, as Ricuarte's claims were used both to justify outlawing ecstasy in the US and as justification for sentencing increases,” the journal added.
http://jnm.snmjournals.org/cgi/content/full/44/3/375
==============================================
Journal of Nuclear Medicine Vol. 44 No. 3 375-384
© 2003 by Society of Nuclear Medicine
--------------------------------------------------------------------------------
Clinical Investigations
Long-Term Effects of "Ecstasy" Use on Serotonin Transporters of the Brain Investigated by PET
Ralph Buchert, PhD1, Rainer Thomasius, MD2, Bruno Nebeling, PhD1, Kay Petersen, PhD2, Jost Obrocki, MD2, Lars Jenicke, MD1, Florian Wilke1, Lutz Wartberg2, Pavlina Zapletalova, MS2 and Malte Clausen, MD1
1 Department of Nuclear Medicine, University Hospital Hamburg-Eppendorf, Hamburg, Germany
2 Department of Psychiatry and Psychotherapy, University Hospital Hamburg-Eppendorf, Hamburg, Germany
Alterations of the serotonergic system due to ecstasy consumption have been extensively documented in recent literature. However, reversibility of these neurotoxic effects still remains unclear. To address this question, PET was performed using the serotonin transporter (SERT) ligand 11C-(+)-McN5652 in a total of 117 subjects subdivided into 4 groups: actual ecstasy users (n = 30), former ecstasy users (n = 29), drug-naive control subjects (n = 29), and subjects with abuse of psychoactive agents other than ecstasy (n = 29). Methods: About 500 MBq 11C-(+)-McN5652 were injected intravenously. Thirty-five scans were acquired according to a dynamic scan protocol of 90 min using a full-ring whole-body PET system. Transaxial slices were reconstructed using an iterative method. Individual brains were transformed to a template defined earlier. Distribution volume ratios (DVRs) were derived by application of a reference tissue approach for reversible binding. Gray matter of the cerebellum served as reference. SERT-rich brain regions—mesencephalon, putamen, caudate, and thalamus—were selected for the evaluation of SERT availability using volumes of interest predefined in the template. Results: Compared with drug-naive control subjects, the DVR in actual ecstasy users was significantly reduced in the mesencephalon (P = 0.004) and the thalamus (P = 0.044). The DVR in former ecstasy users was very close to the DVR in drug-naive control subjects in all brain regions. The DVR in polydrug users was slightly higher than that in the drug-naive control subjects in all SERT-rich regions (not statistically significant). Conclusion: Our findings further support the hypothesis of ecstasy-induced protracted alterations of the SERT. In addition, they might indicate reversibility of the availability of SERT as measured by PET. However, this does not imply full reversibility of the neurotoxic effects.